Toggle navigation
History
Approach
Team
Companies
News Room
Contact
Medicxi launches first $300m late-stage life sciences fund Medicxi Growth 1 (MG1), backed by Novartis and Verily
Press Release
Introducing Medicxi Growth 1, Our First $300m Late-Stage Fund
Blog
